Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France

Active, not recruitingOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

April 28, 2026

Study Completion Date

September 21, 2026

Conditions

Chronic Rhinosinusitis With Nasal Polyposis

Interventions

DRUG

Dupilumab

This study will not administer any treatment, only observe the treatment as prescribed in real world-clinical practice.

Trial Locations (1)

Investigational Site Number: 250.0001, Nantes